You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in China

Feb 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health market continues its robust growth

The consumer health market in China continued its robust development in 2011, with double-digit current value growth. Ongoing urbanisation and the greying population have created substantial market demand for consumer health products, while continuously rising health awareness among consumers has also helped boost sales. The vigorous consumer health market is also being underpinned by the steady development of the economy in China, amid the global financial crisis.

Rx-to-OTC switches restarted in 2011

Rx-to-OTC switches were restarted in 2011 by the State Food and Drug Administration (SFDA), after a suspension of three years. The SFDA published Rx-to-OTC lists twice, with 54 and 48 drugs on the lists, respectively, in February and August 2011. Such switches have had a positive impact on the OTC category in China. Manufacturers have been more proactive in advertising, as well as in consumer education, while at the same time consumers are being provided with more choices in OTC drugs.

Further consolidation of the market

The leading consumer health players have continued to drive consolidation in the market, appealing to consumers with their established brand awareness, wide product portfolios, consistent quality and advanced distribution networks. The top three brands in the consumer health market increased their combined share in 2011. Direct selling companies, such as Amway (China) Co Ltd and Infinitus (China) Co Ltd, have performed particularly well in the consumer health market, aided by high standards of customer service. Amway’s Nutrilite Experience Centre and Infinitus Customer Service Centre have been successful in reaching out to consumers.

Chemists/pharmacies still dominate but outpaced by direct selling in growth

Chemists/pharmacies still lead the retailing of consumer health products in China, accounting for almost half of total value sales. However, thanks to the boom in of direct selling, chemists/pharmacies lost share to the direct selling channel in 2011. Internet retailing, though still something of a niche, is also growing fast, owing to its convenience and competitive pricing. Overall, non-store retailing has considerable potential in the distribution of consumer health products in China.

Steady growth is anticipated out of steady demand

Steady value growth is expected for the consumer health market in China over the forecast period. The anticipated stable economic development, rising consumer health consciousness and the ageing population will be the major growth engines for the market. The OTC category is anticipated to outperform the vitamins and dietary supplements category between 2011 and 2016, as the OTC category is relatively underdeveloped in China.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in China with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in China, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in China for free:

The Consumer Health in China market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in China?
  • What are the major brands in China?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in China - Industry Overview

EXECUTIVE SUMMARY

Consumer health market continues its robust growth

Rx-to-OTC switches restarted in 2011

Further consolidation of the market

Chemists/pharmacies still dominate but outpaced by direct selling in growth

Steady growth is anticipated out of steady demand

KEY TRENDS AND DEVELOPMENTS

Steady economic development underpins the consumer health market

Industry leaders continue to consolidate the market

Greying population fuels sales

Market segmentation drives sales of vitamins and dietary supplements products

The restarting of Rx-to-OTC switches impacts the OTC industry

TERRITORY KEY TRENDS AND DEVELOPMENTS

East China

Mid China

North and Northeast China

Northwest China

South China

Southwest China

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Sales of Consumer Health by Region: Value 2006-2011
  • Table 6 Sales of Consumer Health by Region: % Value Growth 2006-2011
  • Table 7 Consumer Health Company Shares 2007-2011
  • Table 8 Consumer Health Brand Shares 2008-2011
  • Table 9 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 10 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 11 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 12 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
  • Table 13 Forecast Sales of Consumer Health by Region: Value 2011-2016
  • Table 14 Forecast Sales of Consumer Health by Region: % Value Growth 2011-2016

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC – Switches 2009-2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in China - Company Profiles

Amway (China) Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Amway (China) Co Ltd: Competitive Position 2011

CR Sanjiu Medical & Pharmaceutical Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 7 CR Sanjiu Medical & Pharmaceutical Co Ltd: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 8 CR Sanjiu Medical & Pharmaceutical Co Ltd: Competitive Position 2011

Infinitus (China) Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 10 Infinitus (China) Co Ltd: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 11 Infinitus (China) Co Ltd: Competitive Position 2011

Jiangzhong Pharmaceutical Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 14 Jiangzhong Pharmaceutical Co: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 15 Jiangzhong Pharmaceutical Co Ltd: Competitive Position 2011

Perfect (China) Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Perfect (China) Co Ltd: Competitive Position 2011

Shandong Dong-E E-Jiao Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 20 Shandong Dong-E E-jiao Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 21 Shandong Dong-E E-Jiao Co Ltd: Competitive Position 2011

Stone Group Holdings Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 23 Stone Group Holding Ltd: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 24 Stone Group Holding Ltd: Competitive Position 2011

Tibet Cheezheng Tibetan Medicine Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 27 Tibet Cheezheng Tibetan Medicine Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 28 Tibet Cheezheng Tibetan Medicine Co Ltd: Competitive Position 2011

Xian Janssen Pharmaceutical Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 30 Xian Janssen Pharmaceutical Ltd: Competitive Position 2011

Yunnan Baiyao Group Co Ltd in Consumer Health (China)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 33 Yunnan Baiyao Group Co Ltd: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 34 Yunnan Baiyao Group Co Ltd: Competitive Position 2011

Adult Mouth Care in China - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care registered significant current value growth of 8% in 2011, mainly due to growing awareness of personal health and well-being. Rising pressure from life and work, and the growing popularity of hot and spicy diets have given rise to various ailments, such as mouth ulcers. Most consumers tended to ignore such minor ailments, but some turn to OTC products to relieve the symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • Dexamethasone Acetate Adhesive Tablets, from Joincare Pharmaceutical Group Industry Co Ltd, continued to rank first in 2011, with a 51% value share in 2011, up from 50% in 2010. Convenience of application and rapid action are key reasons for its success in the market. Furthermore, the established distribution network of Joincare Pharmaceutical Group has contributed to the strong position of Dexamethasone Acetate Adhesive Tablets in the adult mouth care category.

PROSPECTS

  • The major threat to the adult mouth care category over the forecast period will be oral care products in the beauty and personal care market. Chinese consumers are more likely to opt for oral care products, such as mouthwashes/dental rinses, for their minor oral ailments, instead of medicated adult mouth care products. Oral care products are easier to purchase and to use, and are thus more popular among Chinese consumers.

CATEGORY DATA

  • Table 15 Sales of Adult Mouth Care: Value 2006-2011
  • Table 16 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 17 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 18 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 19 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 20 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in China - Category Analysis

HEADLINES

TRENDS

  • The market for analgesics kept enjoying stable growth in 2011, with current value growth of almost 11% and total sales of RMB5.7 billion. With the gradual all-round implementation of China’s new healthcare reform and the overall improvement of consumer education, awareness of self-medication has increased. Meanwhile, along with accelerated urbanisation, chained chemists/pharmacies have extended further into the rural areas in China, providing people with more convenience to purchase standard systemic analgesics and topical analgesics/anaesthetics to treat minor complaints.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline (Tianjin) Pharm Co Ltd maintained its leading position in analgesics in 2011, with over a 14% value share. The outstanding performance of GlaxoSmithKline (Tianjin) Pharm Co Ltd is mostly underpinned by its mainstay product Fenbid, whose brand image has been enhanced by successful marketing campaigns, including TV advertisements. Furthermore, the company has kept on expanding its distribution network throughout the country in recent years, which has contributed to its rapid growth.

PROSPECTS

  • Over the forecast period, owing to the steady rise of China’s ageing population and increasing awareness of self-medication, it is expected that China’s analgesics market will record a CAGR of more than 6% in constant value terms, reaching RMB7.8 billion at constant 2011 prices in 2016, and per capita expenditure on analgesic products is forecast to rise from RMB4.3 in 2011 to RMB5.7 in 2016.

CATEGORY DATA

  • Table 21 Sales of Analgesics by Category: Value 2006-2011
  • Table 22 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 23 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 24 Analgesics Company Shares by Value 2007-2011
  • Table 25 Analgesics Brand Shares by Value 2008-2011
  • Table 26 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 27 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in China - Category Analysis

HEADLINES

TRENDS

  • In 2011, calming and sleeping products continued to post healthy growth, with a year-on-year value increase of 8%. The major consumer group for calming and sleeping products in China is elderly people, and the steady ageing of the population in China has been a key contributor to the category’s continuing growth. However, in line with the widely spreading concept of a healthy lifestyle, many packaged food market have launched healthy food products which claimed to offer calming and sleeping functions, giving consumers an alternative to specific calming and sleeping products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Jilin Aodong Pharm Group Co Ltd ranked first in China’s calming and sleeping products market during 2011, with a value share of almost 53%. An Shen Bu Nao Ye is the flagship product of the company, and after decades of development the brand has become familiar to local consumers. It has been a sales driver for the company for years, based not only its well-established brand image and good reputation, but also widespread TV advertising.

PROSPECTS

  • Over the forecast period, the calming and sleeping products category is expected to register modest growth, with a CAGR of some 4% in constant value terms. Older people will remain the main consumer group of the calming and sleeping products, and the aging of the Chinese population will continue to contribute to sales growth. As most local consumers tend to regard herbal/traditional calming and sleeping products to be safer than standard ones, herbal/traditional products will continue to dominate China’s calming and sleeping market in the forecast period.

CATEGORY DATA

  • Table 28 Sales of Calming and Sleeping: Value 2006-2011
  • Table 29 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 30 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 31 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 32 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 33 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in China - Category Analysis

HEADLINES

TRENDS

  • Sales of cough, cold and allergy remedies rose by almost 12% in current value terms in 2011 in China. After years of healthy development, aided by consumers’ increased awareness of self-medication, cough, cold and allergy remedies, which is one of the largest categories in China’s OTC market, enjoyed dynamic growth, having gained wide product familiarity among Chinese consumers.

SWITCHES

COMPETITIVE LANDSCAPE

  • CR Sanjiu Medical & Pharmaceutical Co Ltd continued to consolidate its leading position in cough, cold and allergy remedies in 2011. The mainstay product of this company, 999 Gan Mao Ling, continued to see robust growth, aided by successful advertising campaigns and its perceived effectiveness. Thanks to the nationwide popularity of herbal/traditional products, 999 Gan Mao Ling, which provides the combined effect of herbal/traditional products and standard products, has become more popular among Chinese consumers, reaching over a 9% value brand share in the cough, cold and allergy remedies category in 2011.

PROSPECTS

  • The cough, cold and allergy remedies category is forecast to maintain healthy growth between 2011 and 2016, with a CAGR of more than 7% in constant value terms. After many years of development compared with other categories in the OTC category, cough, cold and allergy remedies in China have become relatively stable, with steadily increasing market demand, which is basically in line with the growth of the Chinese population.

CATEGORY DATA

  • Table 34 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Sales of Decongestants by Category: Value 2006-2011
  • Table 37 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 38 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 39 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 40 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 41 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 42 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 43 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in China - Category Analysis

HEADLINES

TRENDS

  • The market for digestive remedies continued to record steady growth in 2011, rising by over 9% in value sales terms, reaching RMB5.2 billion. This was generally in line with the steady upward trend in digestive remedies demand in China. With the acceleration of the pace of life in modern China, more and more young people, in particular white-collar workers, have been suffering digestive problems, stimulating the increase in demand for digestive remedies. However, during the review period there were few new launches in China’s digestive remedies market, and it was the stable performance of the leading brands which was the main contributor to the category’s sustained development.

SWITCHES

COMPETITIVE LANDSCAPE

  • Jilin Xiuzheng Pharmaceutical Co Ltd consolidated its top position in China’s digestive remedies market, accounting for a 17% value share in 2011. The main driving force of its dynamic value sales growth in digestive remedies is the performance of its flagship brand, Si Da Shu, whose brand image has been built up by the company’s significant investment in various marketing activities, including TV commercials.

PROSPECTS

  • The digestive remedies category in China is expected to maintain steady growth between 2011 and 2016. Sales are expected to reach RMB6.6 billion at constant 2011 prices in 2016, following a CAGR of almost 5% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 44 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 45 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 46 Digestive Remedies Company Shares by Value 2007-2011
  • Table 47 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 48 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 49 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Emergency Contraception in China - Category Analysis

HEADLINES

TRENDS

  • Sales of emergency contraception market saw growth of 8% in current value terms in 2011. Owing to public’s concern about the side effects of emergency contraception products, especially the ones with levonorgestrel as active ingredient, the growth rate in this category slowed down slightly over the review period. However, sales value continued to grow in 2011, as demand for emergency contraception remained strong.

COMPETITIVE LANDSCAPE

  • In the emergency contraception category, the ranking of the leading companies remained unchanged in 2011. Domestic brands continued to dominate. Beijing Zizhu Pharm Co Ltd retained its leading position in 2011, with a value share of 49%. Its main products, Yuting and Gold Yuting, are still the first choice for many consumers, owing to their established brand awareness.

PROSPECTS

  • Emergency contraception is expected to continue to see steady growth, with a CAGR of 3% in constant value terms over the forecast period, to reach a sales value of almost RMB1.5 billion in 2016. The positive growth trend will largely be attributable to changing attitudes to pre-marital sex in China.

CATEGORY DATA

  • Table 50 Sales of Emergency Contraception: Value 2006-2011
  • Table 51 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 52 Emergency Contraception Company Shares by Value 2007-2011
  • Table 53 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 54 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 55 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in China - Category Analysis

HEADLINES

TRENDS

  • Eye care in China continued its healthy growth in 2011, thanks to growing consumer awareness and wider availability of eye care products. Long-term exposure to computers gives rise to more occasions of eye fatigue, especially among young consumers and white collar workers, resulting in rising demand for eye care products in the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Mioclear, from Shandong Bausch & Lomb Freda Pharmaceutical Co Ltd, continue to lead in 2011, with a value share of 25%, up from 23% in 2010. With a clear market positioning, targeting heavy readers, contact lens users and computer users with fatigued eyes, Mioclear is aggressive in marketing and advertising, even though the brand already enjoys high awareness among consumers.

PROSPECTS

  • A moderate value CAGR of around 4% is expected for the eye care category in China between 2011 and 2016. The large population of computer users will constitute the major consumer group for eye care products.

CATEGORY DATA

  • Table 56 Sales of Eye Care by Category: Value 2006-2011
  • Table 57 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 58 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 59 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 60 Eye Care Company Shares by Value 2007-2011
  • Table 61 Eye Care Brand Shares by Value 2008-2011
  • Table 62 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 63 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in China - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products registered dynamic growth during 2011. More and more consumers have been placing more emphasis on high quality healthcare products with fewer side effects, and manufacturers have been making continuous efforts to improve herbal/traditional product quality, as well as increasing brand recognition through heavy investment in TV commercials and other marketing campaigns.

COMPETITIVE LANDSCAPE

  • Infinitus (China) Co Ltd ranked first in herbal/traditional products in China in 2011, with a value share of over 9%, up from 8% in 2010. In addition to a wide product portfolio of herbal/traditional products with traditional Chinese herbs as the major ingredients, such as lingzhi and hawthorn, the company focused on customer service in the review period and has developed many loyal customers all over the country. To better serve its customers, the company upgraded its local service stations across China in 2011.

PROSPECTS

  • It is expected that herbal/traditional products market will witness strong growth over the forecast period, with a CAGR of almost 8% in constant value terms. The established preference for herbal ingredients among Chinese consumers, as well as the greater concentration on herbal/traditional products R&D by manufacturers, will be the main driving forces for the healthy growth momentum in the forecast period.

CATEGORY DATA

  • Table 64 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 65 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 66 Herbal/Traditional Products Company Shares 2007-2011
  • Table 67 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 68 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 69 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in China - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care is one of the most important OTC categories in China, with sales value reaching RMB7.7 billion in 2011, up by 11% from 2010. Increasing air and water pollution in China has led to more people suffering from chronic skin diseases in recent years. A mixture of improved education levels and rising disposable incomes in both urban and rural areas in China, coupled with negative environmental factors, drove medicated skin care sales over the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Xian Janssen Pharmaceutical Ltd continued to be the leading company in medicated skin care in 2011, with a value share of over 19%, more than three times the share of the second ranked player. The company’s core brands, Daktarin and Pevisone, both realised stable and sustained growth during the review period and maintained the company’s leading position in the market. Good brand awareness built by many years’ efforts in terms of TV advertising, and an extensive distribution network established by decades of expansion across the country have been major factors in its success in the market.

PROSPECTS

  • Sales of medicated skin care will continue to maintain steady growth over the forecast period, owing to the rising incidence of chronic skin diseases, as well as improved awareness of self-medication in general. Sales are predicted to reach RMB10.8 billion at constant 2011 prices in 2016, with a CAGR of 7% in constant value terms between 2011 and 2016.

CATEGORY DATA

  • Table 70 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 71 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 72 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 73 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 74 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 75 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 76 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in China - Category Analysis

HEADLINES

TRENDS

  • Growth in the number of smokers in China slowed slightly during the review period, thanks to the efforts made by the Chinese government to reduce smoking. However, the total number of smokers was still substantial in 2011, as Chinese have long regarded smoking as a traditional way of social networking, and government regulation is not as strict as other in countries, which has hampered sales growth of NRT smoking cessation aids in the market to a significant extent.

SWITCHES

COMPETITIVE LANDSCAPE

  • Although Shanghai Johnson & Johnson has made great efforts to promote its products, sales value of Nicorette gum and patches still did not perform as well as expected in 2011, due to the relatively high unit prices and limited consumer awareness of smoking cessation aids.

PROSPECTS

  • Despite the efforts being made by the Chinese government to implement stronger smoking controls by means of setting up more non-smoking zones in public places and improving education on smoking’s harmfulness to health, China is still a relatively smoking-tolerant country. The number of smokers is expected to post a steady rise in the forecast period, with tax rises and other smoking control policies having little impact on sales growth of tobacco in China. Meanwhile, with the failure of implementation of new smoking control regulations in 2010 and 2011, the number of smokers in public places did not see a decline in 2011, and the target of setting up smoke-free public areas was postponed until the end of 2015. Therefore, the NRT smoking cessation aids category will still be negligible in the short term.

Sports Nutrition in China - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition sales maintained an upward trend, with growth of 13% in current value terms in 2011, mainly due to powerful marketing on the part of manufacturers, and growing awareness of fitness among consumers. With rising disposable incomes, consumers are willing to spend more on personal well-being, including physical fitness.

COMPETITIVE LANDSCAPE

  • Beijing Competitor Sports Technology Joint Stock Co Ltd ranks first in the sports nutrition category, with a share of almost 50% in value terms in 2011, followed by Guangzhou By-health Biological Engineering Co Ltd, with a share of 27%, and Shenzhen UN Sports Nutrition Co Ltd, with a share of nearly 10%. Rapid expansion in the mass market and the outstanding performance of new distribution channels in terms of value sales, such as internet retailing, consolidated Competitor’s leading position in the domestic sports nutrition market.

PROSPECTS

  • Sports nutrition is predicted to see a constant value CAGR of 9% between 2011 and 2016, with sales reaching RMB391 million at constant 2011 prices. The trend is expected to be positive in the forecast period, as keeping fit is more and more popular, and demand for personalised advice regarding dietary formulas and nutritional supplements is rising among mass-market consumers in China. Meanwhile, the value growth rate of sports nutrition is expected to witness a steady decline, due to the relatively segmented market and the public’s greater desire for more personalized products.

CATEGORY DATA

  • Table 77 Sales of Sports Nutrition: Value 2006-2011
  • Table 78 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 79 Sports Nutrition Company Shares 2007-2011
  • Table 80 Sports Nutrition Brand Shares 2008-2011
  • Table 81 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 82 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in China - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements experienced robust current value growth in 2011, mainly thanks to the fast-growing greying population in China, and rising health awareness among consumers. Increasing disposable incomes and a growing number of time-pressed consumers in pursuit of healthy lifestyles also contributed to the vigorous growth of vitamins and dietary supplements in 2011.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Amway holds a comfortable lead in the vitamins and dietary supplements category, with a value share of 17% in 2011. One of its signature products, protein powder, has registered a strong performance in the local market, thanks to its established brand awareness among consumers, a wide product portfolio, consistent product quality as well as an extensive sales network through its direct selling team, over 340 direct selling shops and 17 consumer experience centres across China. Unit price rises for Amway products have contributed to value growth.

PROSPECTS

  • The vitamins and dietary supplements category is expected to experience a steady value CAGR of 5% between 2011 and 2016, with demand being driven the greying population and rising healthcare consciousness among consumers in general. Furthermore, the improving living standards arising from years of robust economic development have made vitamins and dietary supplements products increasingly affordable for average consumers.

CATEGORY DATA

  • Summary 35 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 83 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 84 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 85 Dietary Supplements by Positioning 2006-2011
  • Table 86 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 87 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 88 Vitamins Brand Shares by Value 2008-2011
  • Table 89 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 90 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 91 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in China - Category Analysis

HEADLINES

TRENDS

  • Weight management products enjoyed strong current value growth in 2011, of 9%, mainly due to robust growth in the mainstay product, slimming tea. As a traditional tea-drinking country, China boasts a large consumer group of regular tea drinkers. Thanks to growing awareness of personal well-being, more consumers are paying attention to their appearance, including weight management. Slimming tea provides both convenience and a weight management function, and thus is the most popular category within weight management among Chinese consumers.

COMPETITIVE LANDSCAPE

  • Herbalife (China) Health Products Ltd takes the lead in weight management in China, with a value share of 12% in 2011, up from 11% in 2010. The company’s almost monopoly position in the meal replacement slimming category, with a value share of over 87% in 2011, has contributed to its overall outstanding performance in the total weight management category in China. Meanwhile, the company’s extensive product portfolio in the vitamins and dietary supplements market also boosted its brand awareness in the weight management category in the review period.

PROSPECTS

  • The weight management category is expected to experience a steady value CAGR of 5% over the forecast period, driven by continued demand for slimming products in response to rising awareness of personal appearance among Chinese consumers. Rising disposable incomes and growing health consciousness will also underpin demand over the forecast period.

CATEGORY DATA

  • Table 92 Sales of Weight Management: Value 2006-2011
  • Table 93 Sales of Weight Management: % Value Growth 2006-2011
  • Table 94 Weight Management Company Shares 2007-2011
  • Table 95 Weight Management Brand Shares 2008-2011
  • Table 96 Forecast Sales of Weight Management: Value 2011-2016
  • Table 97 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in China - Category Analysis

HEADLINES

TRENDS

  • The market for wound care products experienced steady growth in 2011, mainly thanks to the continuous contributions of leading companies, in particular Yunnan Baiyao Group Co Ltd and Shanghai Johnson & Johnson Ltd. With the overall improvement in consumer educational levels, Chinese consumers have been more accustomed to using sticking plasters to treat less serious injuries.

COMPETITIVE LANDSCAPE

  • During the review period, Yunnan Baiyao Group Co Ltd consolidated its leading position in China’s wound care products market, with its share reaching almost 46% in value terms in 2011. Enjoying more than 10 years of development, the company not only highlights its medicated ingredients as its major selling point, but also has the competitive advantage of relatively low selling prices, especially compared with its strong competitor Band-Aid, from Shanghai Johnson & Johnson Ltd. In order to strengthen its competitiveness and promote brand recognition, Yunnan Baiyao Group Co Ltd has paid continuous attention to distribution network improvement, which has been another key contributor to its dynamic growth.

PROSPECTS

  • The wound care category in China is relatively stable in terms of market demand compared with other OTC categories, and is expected to see only modest growth between 2011 and 2016, largely in line with the steady growth in China’s population.

CATEGORY DATA

  • Table 98 Sales of Wound Care by Category: Value 2006-2011
  • Table 99 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 100 Wound Care Company Shares by Value 2007-2011
  • Table 101 Wound Care Brand Shares by Value 2008-2011
  • Table 102 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 103 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Lingzhi
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • E-Jiao
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!